US & China Slash Tariffs to Boost Trade
These carefully selected stocks could see growth as the US and China significantly lower trade tariffs. Our analysts have identified companies positioned to benefit from increased trade between the world's two largest economies.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Unlock all stocks by downloading the app for FREE.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
This collection focuses on companies that stand to benefit from reduced trade tensions between the US and China. With tariffs dropping dramatically (US from 145% to 30%, China from 125% to 10%), these stocks could see improved business conditions and investor confidence.
What You Need to Know
This 90-day tariff reduction represents a temporary easing of trade tensions that could reduce market uncertainty. While the long-term outlook depends on whether a more conclusive deal is reached by August 2025, these selected companies may benefit from this trading window.
Why These Stocks
We've handpicked big-name US and Chinese stocks that rely heavily on cross-border business or have significant market presence in both countries. These companies are potentially positioned to capitalize on increased trade activity and improved business sentiment.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+11.35%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 11.35% over the next year.
Stocks Rated Buy by Analysts
8 of 11 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 2% return last month.
Why You'll Want to Watch These Stocks
Global Trade Revival
As tariffs drop dramatically (US from 145% to 30%, China from 125% to 10%), these companies could see immediate benefits from reduced costs and increased business activity across borders.
Market Momentum Opportunity
Markets have already started responding positively to the tariff cuts. Getting in now could position you to benefit if the 90-day window leads to a more permanent trade agreement.
First-Mover Advantage
While many investors are still figuring out what these tariff cuts mean, you can get ahead by focusing on these carefully selected companies already positioned to benefit from US-China trade improvements.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Orphan Drug Moats: Leaders In Rare Disease
The FDA's rejection of PTC Therapeutics' drug for a rare genetic disorder has delayed a new treatment option and created a significant setback for the company. This regulatory decision strengthens the competitive position of companies with already-approved therapies for rare diseases, highlighting the value of a proven drug portfolio.
Nvidia's China Chip Pivot
Nvidia is developing a new, compliant AI chip for China, aiming to recapture market share lost to U.S. export controls. This strategic pivot creates a ripple effect, potentially benefiting the entire semiconductor supply chain that supports the production and deployment of this advanced hardware.
Navigating The Autonomous Driving Shakeout
A class-action lawsuit against Tesla regarding its Full Self-Driving claims puts the company's marketing and technology under intense scrutiny. This legal challenge could boost demand for competing autonomous driving technologies, creating opportunities for companies that supply advanced sensors and software.
Frequently Asked Questions
Everything you need to know about the product and billing.